A detailed history of Relative Value Partners Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 27,966 shares of MRK stock, worth $2.7 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
27,966
Previous 9,721 187.69%
Holding current value
$2.7 Million
Previous $1.28 Million 170.05%
% of portfolio
0.46%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $2.26 Million - $2.43 Million
18,245 Added 187.69%
27,966 $3.46 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $2,717 - $3,166
24 Added 0.25%
9,721 $1.28 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $58,104 - $63,231
-580 Reduced 5.64%
9,697 $1.06 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $220,724 - $245,123
2,144 Added 26.36%
10,277 $1.06 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $74,528 - $83,158
-724 Reduced 8.17%
8,133 $865,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $292,486 - $375,007
3,345 Added 60.69%
8,857 $982,000
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $465,929 - $523,419
5,512 New
5,512 $475,000
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $667,920 - $757,120
-8,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $220,530 - $247,200
3,000 Added 60.0%
8,000 $662,000
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $220,281 - $243,653
-3,133 Reduced 38.52%
5,000 $392,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $224,855 - $249,543
3,133 Added 62.66%
8,133 $671,000
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $31,680 - $43,910
500 Added 11.11%
5,000 $387,000
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $6,984 - $8,159
-100 Reduced 2.17%
4,500 $380,000
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $6,958 - $7,936
100 Added 2.22%
4,600 $385,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,500
4,500 $288,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.